StockData
Vyome Holdings, Inc logo

Vyome Holdings, Inc (HIND) stock

HINDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$1.54+0.01 (+0.98%)

Close on Nov 17, 2026Market cap $10.84MP/E –Yield –

Vyome price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Vyome's price to sales ratio was 84.9× on Nov 11, 2026, against 0.3× a year earlier. Over the last 5 years it ranged from 0.0× to 116.9×, with a median of 0.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202684.9×+84.7
2025Oct 31, 20250.2×−0.1
2024Dec 31, 20240.3×+0.2
2023Dec 29, 20230.0×−0.1
2022Dec 30, 20220.1×−0.9
2021Dec 31, 20211.0×−1.4
2020Dec 31, 20202.5×−2.3
2019Dec 31, 20194.7×−2.0
2018Dec 31, 20186.7×−18.0
2017Dec 29, 201724.7×–

More Vyome figures

See a number that looks wrong?